2 Early Canadian Leaders Ready to Soar on Buyout Rumors

October 30, 2017 was one of the best days of the year for the young cannabis industry.

That’s the date when Constellation Brands (NYSE: STZ), the second-largest US beer maker, announced a 10% stake in Canopy Growth (NYSE: CGC), the largest Canadian cannabis company.

It was a groundbreaking moment for the cannabis industry because it was the first time that a big alcohol company had invested directly in a cannabis company. Continue reading “2 Early Canadian Leaders Ready to Soar on Buyout Rumors”

GW Pharmaceuticals’ FDA Win Reinforces BofA’s Bullish Thesis

The U.S. Food and Drug Administration approval of GW Pharmaceuticals PLC (NASDAQ: GWPH)’s epidiolex therapy for the treatment of seizures was expected — and reinforces the bullish case for owning the stock, according to Bank of America Merrill Lynch. Continue reading “GW Pharmaceuticals’ FDA Win Reinforces BofA’s Bullish Thesis”

New Entry into Germany’s Cannabis Industry up 475% in 12 Months

Germany has quickly emerged as one of the fastest-growing medical cannabis markets in the world.

According to a study on the German health insurance market, 500 German patients requested medical cannabis in January of 2017.

In December of the same year, the number of patients requesting reimbursements for cannabis prescriptions skyrocketed to 13,000.

What was the biggest factor that drove the huge spike? Continue reading “New Entry into Germany’s Cannabis Industry up 475% in 12 Months”

Colorado marijuana bus tours view themselves as industry ambassadors

“Welcome to the party bus.”

That’s what tour guide Alyse Morgan told 20-plus tourists who were riding in a marijuana bus tour on a hot May Friday. It was a rare chance for them to consume a plant that’s likely illegal in their home states. Continue reading “Colorado marijuana bus tours view themselves as industry ambassadors”

Leading Cannabis Biotech Could Soar on June 27

Blockbuster drugs are the holy grail of the pharmaceutical industry.

When annual sales of a hot new drug break the $1 billion mark, investors are usually rewarded with big gains.

This is what began happening in 2012 with Gilead Science (Nasdaq: GILD).

In 2013, the FDA approved Gilead’s hepatitis C drug Sovaldi. Continue reading “Leading Cannabis Biotech Could Soar on June 27”

Illinois Lawmakers Approve Measure To Allow Medical Marijuana As Prescription Painkiller Substitute

Illinois lawmakers have approved a measure not only to allow medical marijuana to be used in place of prescription painkillers, but to eliminate requirements for patients to get fingerprints and criminal background checks. Continue reading “Illinois Lawmakers Approve Measure To Allow Medical Marijuana As Prescription Painkiller Substitute”

Marijuana ‘Tasting Rooms’ Bill Dies With Colorado Gov.’s Veto

Colorado’s governor on Monday vetoed a bill to allow marijuana retailers to set up “tasting rooms,” dashing hopes that the state would be the first to adopt a system letting consumers use marijuana in public spaces.

 

Continue reading “Marijuana ‘Tasting Rooms’ Bill Dies With Colorado Gov.’s Veto”